Cencora, Inc. (BIT:1COR)

Italy flag Italy · Delayed Price · Currency is EUR
277.30
-36.80 (-11.72%)
At close: Dec 5, 2025
11.61%
Market Cap 56.64B
Revenue (ttm) 273.87B
Net Income (ttm) 1.32B
Shares Out n/a
EPS (ttm) 6.78
PE Ratio 42.76
Forward PE 19.25
Dividend 1.56 (0.53%)
Ex-Dividend Date Nov 13, 2025
Volume n/a
Average Volume 1
Open n/a
Previous Close 314.10
Day's Range n/a
52-Week Range 237.46 - 330.95
Beta n/a
RSI 38.48
Earnings Date Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1871
Employees 51,000
Stock Exchange Borsa Italiana
Ticker Symbol 1COR
Full Company Profile

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.